secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-07-01T19:28:22+00:00
Accession:  0001213900-26-074182
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs furnishes investor presentation for July 1 webinar; no material new information disclosed
--------------------------------------------------------------------------------

- Presentation furnished as Exhibit 99.1 for Regulation FD purposes.
- No specific financial or operational data provided in the filing.
- Company intends to use materials in investor webinar on July 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026074182/0001213900-26-074182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026074182/ea0296736-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-074182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer